Given the potential role of RIPK3 in migration and invasion, we used GSK872, a specific RIPK3 inhibitor, to suppress RIPK3 expression and assess its effect on pH 6.8-induced RA-FLSs migration and invasion. This evidence concerns the gene RIPK3 and rheumatoid arthritis.